Evidence map›Paper›PMID 36077351›Full record

ArticleInternational journal of molecular sciences2022

A Bioengineering Approach for the Development of Fibroblast Growth Factor-7-Functionalized Sericin Biomaterial Applicable for the Cultivation of Keratinocytes.

Ai Ai Lian, Yuka Yamaji, Kazuki Kajiwara, Keiko Takaki, Hajime Mori, Mervyn Wing On Liew, Eiji Kotani, Rina Maruta

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Recycled Sericin Biopolymer in Biotechnology and Bioelectronics.Bioengineering (Basel, Switzerland) · 2025
    Review
  4. Review
  5. Article
  6. SericinInsects · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Ai Ai LianDepartment of Applied Biology, Kyoto Institute of Technology, Sakyo-ku, Kyoto 606-8585, Japan.
Yuka YamajiDepartment of Applied Biology, Kyoto Institute of Technology, Sakyo-ku, Kyoto 606-8585, Japan.
Kazuki KajiwaraDepartment of Applied Biology, Kyoto Institute of Technology, Sakyo-ku, Kyoto 606-8585, Japan.
Keiko TakakiDepartment of Applied Biology, Kyoto Institute of Technology, Sakyo-ku, Kyoto 606-8585, Japan.ORCID 0000-0002-9525-370X
Hajime MoriDepartment of Applied Biology, Kyoto Institute of Technology, Sakyo-ku, Kyoto 606-8585, Japan.
Mervyn Wing On LiewInstitute for Research in Molecular Medicine, Universiti Sains Malaysia, Minden 11800, Penang, Malaysia.
Eiji KotaniDepartment of Applied Biology, Kyoto Institute of Technology, Sakyo-ku, Kyoto 606-8585, Japan.ORCID 0000-0001-9372-4312
Rina MarutaDepartment of Applied Biology, Kyoto Institute of Technology, Sakyo-ku, Kyoto 606-8585, Japan.
Kyoto Institute of Technology · JPUniversiti Sains Malaysia · MY

Funding

Japan Science and Technology Agency JPMJTM20ESJapan Science and Technology Agency JPMJTR21U5
6 · The paper itself

Abstract

Growth factors, including fibroblast growth factor-7 (FGF-7), are a group of proteins that stimulate various cellular processes and are often used with carriers to prevent the rapid loss of their activities. Sericin with great biocompatibility has been investigated as a proteinaceous carrier to enhance the stability of incorporated proteins. The difficulties in obtaining intact sericin from silkworm cocoons and the handling of growth factors with poor stability necessitate an efficient technique to incorporate the protein into a sericin-based biomaterial. Here, we report the generation of a transgenic silkworm line simultaneously expressing and incorporating FGF-7 into cocoon shells containing almost exclusively sericin. Growth-factor-functionalized sericin cocoon shells requiring simple lyophilization and pulverization processes were successfully used to induce the proliferation and migration of keratinocytes. Moreover, FGF-7 incorporated into sericin-cocoon powder exhibited remarkable stability, with more than 70% of bioactivity being retained after being stored as a suspension at 25 °C for 3 months. Transgenic sericin-cocoon powder was used to continuously supply biologically active FGF-7 to generate a three-dimensionally cultured keratinocyte model in vitro. The outcomes of this study propound a feasible approach to producing cytokine-functionalized sericin materials that are ready to use for cell cultivation.

Indexed as

BombyxSericinsAnimalsAnimals, Genetically ModifiedBiocompatible MaterialsBioengineeringKeratinocytesPowdersBiocompatible MaterialsPowdersSericinsbioengineeringbiomaterialsgrowth factorsprotein stabilitysericintransgenic silkworms

Identifiers

PMID36077351
PMCPMC9456417
OpenAlexW4294152369

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.